The role and mechanisms of action of microRNAs in cancer drug resistance
W Si, J Shen, H Zheng, W Fan - Clinical epigenetics, 2019 - Springer
MicroRNAs (miRNAs) are small non-coding RNAs with a length of about 19–25 nt, which
can regulate various target genes and are thus involved in the regulation of a variety of …
can regulate various target genes and are thus involved in the regulation of a variety of …
Synergy effects of herb extracts: pharmacokinetics and pharmacodynamic basis
Y Yang, Z Zhang, S Li, X Ye, X Li, K He - Fitoterapia, 2014 - Elsevier
Herbal medicine, especially traditional Chinese medicine and Ayurvedic medicine have
played and still play an important role in fighting against various diseases. Emerging clinical …
played and still play an important role in fighting against various diseases. Emerging clinical …
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
CL Au Yeung, NN Co, T Tsuruga, TL Yeung… - Nature …, 2016 - nature.com
Advanced ovarian cancer usually spreads to the visceral adipose tissue of the omentum.
However, the omental stromal cell-derived molecular determinants that modulate ovarian …
However, the omental stromal cell-derived molecular determinants that modulate ovarian …
Comprehensive analysis of microRNA (miRNA) in cancer cells
MicroRNAs (miRNA) are a group of small non-coding RNAs that regulate gene expression
at the RNA level. MicroRNAs have positive regulatory effects on protein translation …
at the RNA level. MicroRNAs have positive regulatory effects on protein translation …
Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
Background Cisplatin-based chemotherapy is frequently used to treat advanced gastric
cancer (GC). However, the resistance often occurs with the mechanisms being not well …
cancer (GC). However, the resistance often occurs with the mechanisms being not well …
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
Drug resistance remains a major hurdle to successful cancer treatment, being accountable
for approximately 90% of cancer-related deaths. In the past years, increasing attention has …
for approximately 90% of cancer-related deaths. In the past years, increasing attention has …
The role of microRNAs in colorectal cancer
Colorectal cancer (CRC) is still the third most common cancer in the world. Mechanism of
CRC tumorigenesis has been widely studied at the molecular levels, and has been recently …
CRC tumorigenesis has been widely studied at the molecular levels, and has been recently …
Arsenic-induced changes in miRNA expression in cancer and other diseases
Abstract miRNAs (miRNA) are essential players regulating gene expression affecting
cellular processes contributing to disease development. Dysregulated miRNA expression …
cellular processes contributing to disease development. Dysregulated miRNA expression …
miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells
D Chen, W Si, J Shen, C Du, W Lou, C Bao… - Cell death & …, 2018 - nature.com
Drug resistance remains a major problem in the treatment of conventional chemotherapeutic
agents in breast cancers. Owing to heterogeneity and complexity of chemoresistance …
agents in breast cancers. Owing to heterogeneity and complexity of chemoresistance …
The network of non-coding RNAs in cancer drug resistance
F Corrà, C Agnoletto, L Minotti, F Baldassari… - Frontiers in …, 2018 - frontiersin.org
Non-coding RNAs (ncRNAs) have been implicated in most cellular functions. The disruption
of their function through somatic mutations, genomic imprinting, transcriptional and post …
of their function through somatic mutations, genomic imprinting, transcriptional and post …